NCT02401646

Brief Summary

The aim of this study is to identify the effect of Polygoni Multiflori Radix complex extract on memory improvement using Rey-Kim scale for healthy people.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Mar 2015

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2015

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2015

Completed
29 days until next milestone

First Posted

Study publicly available on registry

March 30, 2015

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

March 30, 2015

Status Verified

March 1, 2015

Enrollment Period

8 months

First QC Date

February 25, 2015

Last Update Submit

March 24, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline on Memory Quotient score at 2 weeks and 4 weeks

    baseline, at 2 weeks after taking experimental or placebo dietary supplement, at 4 weeks after taking supplement

Secondary Outcomes (4)

  • Change from baseline in Memory registration at 2 weeks and 4 weeks

    baseline, at 2 weeks after taking experimental or placebo dietary supplement, at 4 weeks after taking supplement

  • Change from baseline in Memory retention at 2 weeks and 4 weeks

    baseline, at 2 weeks after taking experimental or placebo dietary supplement, at 4 weeks after taking supplement

  • Change from baseline in Retrieval efficiency at 2 weeks and 4 weeks

    baseline, at 2 weeks after taking experimental or placebo dietary supplement, at 4 weeks after taking supplement

  • Change from baseline in Copy-recall difference index at 2 weeks and 4 weeks

    baseline, at 2 weeks after taking experimental or placebo dietary supplement, at 4 weeks after taking supplement

Study Arms (2)

Polygoni Multiflori Radix complex

EXPERIMENTAL

Participants randomized to the experimental group will take one capsule of Polygoni Multiflori Radix complex extract (250mg) twice a day, 30 minutes after breakfast and dinner for 4 weeks.

Dietary Supplement: Polygoni Multiflori Radix complex extract

Starch

PLACEBO COMPARATOR

Participants randomized to the placebo group will take one capsule of placebo(250mg) twice a day, 30 minutes after breakfast and dinner for 4 weeks.

Dietary Supplement: Placebo

Interventions

Intervention is manufactured by Chun-Ho food

Polygoni Multiflori Radix complex
PlaceboDIETARY_SUPPLEMENT

The placebo is filled with starch, so does not contain the active ingredient.

Starch

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A person who is more than 50 years and lesser than 70 years of age
  • A person who's MQ(Memory Quotient) score is within more than 70 and lesser than 120

You may not qualify if:

  • The patient who has past history related to memory
  • The patient who has Diabetes Mellitus
  • The person whose fasting blood sugar is more than 126mg/dL
  • The patients who has uncontrolled hypertension
  • The patient who has liver disorders
  • The patient whose AST(aspartate aminotransferase) or ALT(alanine aminotransferase) level is more than 60 IU/L(international units per liter)
  • The patients who has heart disorders (Angina pectoris, Myocardial infarction)
  • The patient who has past history related to excision of G-I tract excluding cecum
  • The patient who took drug or heal functional food within 4 weeks before screening
  • The patient who took decoction of herb within 4 weeks before screening
  • The patient who can't write or communicate
  • pregnant woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pusan National University Korean Medicine Hospital

Yangsan, Gyeongsangnam-do, 626-770, South Korea

Location

Study Officials

  • In Lee, Doctor

    Pusan National University Korean Medicine Hospital

    STUDY CHAIR
  • Hye-lim Park, Master

    Pusan National University Korean Medicine Hospital

    PRINCIPAL INVESTIGATOR
  • Eunhye Jeong, bachelor

    National Clinical Research Center for Korean Medicine Pusan National University Korean Medicine Hospital

    PRINCIPAL INVESTIGATOR
  • Hana Lee, bachelor

    National Clinical Research Center for Korean Medicine Pusan National University Korean Medicine Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2015

First Posted

March 30, 2015

Study Start

March 1, 2015

Primary Completion

November 1, 2015

Study Completion

December 1, 2015

Last Updated

March 30, 2015

Record last verified: 2015-03

Locations